Also known as PTC124, 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid, EC-000.2051
Ataluren, sold under the brand name Translarna, is a medication for the treatment of Duchenne muscular dystrophy. It was designed by PTC Therapeutics.
Ataluren, sold under the brand name Translarna, is a medication for the treatment of Duchenne muscular dystrophy. It was designed by PTC Therapeutics.
==Medical use== Ataluren is used in the European Union to treat people with Duchenne muscular dystrophy who have a nonsense mutation in the dystrophin gene, can walk, and are more than five years old.
via Wikipedia infobox
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).